Compliance Feasibility Study for Remote Phase 2 Cardiac Rehabilitation
NCT ID: NCT03491982
Last Updated: 2019-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2018-03-19
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
NCT01430936
Efficacy, Safety and Cost of Remote Monitoring of Patients With Cardiac Resynchronization Therapy
NCT03012490
SVC Occlusion in Subjects With Acute Decompensated Heart Failure
NCT03836079
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
NCT05291884
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
NCT00957541
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We are testing the hypothesis that cardiac rehab compliance will be greater if patients are offered the opportunity, and associated technology, to perform cardiac rehab anywhere.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Cardiac Rehab
Remote Cardiac Rehab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* dementia
* syncope
* valvular disease
* life expectancy \< 1 year
* non-English speaking
* unstable angina
* decompensated congestive heart failure
* ventricular arrhythmia
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Louis University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Alderson MD, F.A.C.C.
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Alderson, MD
Role: PRINCIPAL_INVESTIGATOR
St. Louis University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Louis University - SLUCare
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
28544
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.